Welcome to LookChem.com Sign In|Join Free
  • or
(E)-β-(4-Methoxyphenyl)-4'-methoxyacrylophenone, commonly known as curcumin III, is a naturally occurring chemical compound belonging to the curcuminoid class. It is derived from the turmeric plant and has garnered significant attention for its potential therapeutic properties, which include antioxidant, anti-inflammatory, anticancer, neuroprotective, and antidiabetic effects. The unique chemical structure and diverse biological activities of curcumin III render it a promising candidate for pharmaceutical and medicinal research and applications.

41564-67-4

Post Buying Request

41564-67-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

41564-67-4 Usage

Uses

Used in Pharmaceutical Applications:
(E)-β-(4-Methoxyphenyl)-4'-methoxyacrylophenone is used as a therapeutic agent for its antioxidant and anti-inflammatory properties, which can help alleviate various health conditions and promote overall well-being.
Used in Anticancer Applications:
In the field of oncology, (E)-β-(4-Methoxyphenyl)-4'-methoxyacrylophenone is used as an anticancer agent, targeting a wide range of cancer types. Its potential to modulate multiple oncological signaling pathways and demonstrate synergistic effects when combined with conventional chemotherapeutic drugs makes it a valuable asset in the fight against cancer.
Used in Neuroprotective Applications:
(E)-β-(4-Methoxyphenyl)-4'-methoxyacrylophenone is used as a neuroprotective agent, offering potential benefits for individuals suffering from neurodegenerative diseases or conditions that affect the nervous system.
Used in Antidiabetic Applications:
In the context of diabetes management, (E)-β-(4-Methoxyphenyl)-4'-methoxyacrylophenone is used as an antidiabetic agent, potentially aiding in the regulation of blood sugar levels and improving overall metabolic health.
Used in Drug Delivery Systems:
To enhance the bioavailability and therapeutic outcomes of (E)-β-(4-Methoxyphenyl)-4'-methoxyacrylophenone, it is used in conjunction with various drug delivery systems, such as organic and metallic nanoparticles, to improve its delivery and efficacy in targeted applications.
Used in the Food Industry:
(E)-β-(4-Methoxyphenyl)-4'-methoxyacrylophenone, as a component of turmeric, is used as a natural coloring agent and flavor enhancer in the food industry, adding a vibrant yellow hue and unique taste to various dishes and products.
Used in Cosmetic Applications:
In the cosmetics industry, (E)-β-(4-Methoxyphenyl)-4'-methoxyacrylophenone is used for its antioxidant and anti-inflammatory properties, which can help improve skin health, reduce inflammation, and protect against environmental stressors.

Check Digit Verification of cas no

The CAS Registry Mumber 41564-67-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,5,6 and 4 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 41564-67:
(7*4)+(6*1)+(5*5)+(4*6)+(3*4)+(2*6)+(1*7)=114
114 % 10 = 4
So 41564-67-4 is a valid CAS Registry Number.

41564-67-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (E)-3-(3,5-dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one

1.2 Other means of identification

Product number -
Other names 4,4'-DIMETHOXYCHALCONE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:41564-67-4 SDS

41564-67-4Relevant academic research and scientific papers

Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors

Mellado, Marco,González, César,Mella, Jaime,Aguilar, Luis F.,Vi?a, Dolores,Uriarte, Eugenio,Cuellar, Mauricio,Matos, Maria J.

, (2021/02/12)

Monoamine oxidases (MAOs) are important targets in medicinal chemistry, as their inhibition may change the levels of different neurotransmitters in the brain, and also the production of oxidative stress species. New chemical entities able to interact selectively with one of the MAO isoforms are being extensively studied, and chalcones proved to be promising molecules. In the current work, we focused our attention on the understanding of theoretical models that may predict the MAO-B activity and selectivity of new chalcones. 3D-QSAR models, in particular CoMFA and CoMSIA, and docking simulations analysis have been carried out, and their successful implementation was corroborated by studying twenty-three synthetized chalcones (151–173) based on the generated information. All the synthetized molecules proved to inhibit MAO-B, being ten out of them MAO-B potent and selective inhibitors, with IC50 against this isoform in the nanomolar range, being (E)-3-(4-hydroxyphenyl)-1-(2,2-dimethylchroman-6-yl)prop-2-en-1-one (152) the best MAO-B inhibitor (IC50 of 170 nM). Docking simulations on both MAO-A and MAO-B binding pockets, using compound 152, were carried out. Calculated affinity energy for the MAO-A was +2.3 Kcal/mol, and for the MAO-B was ?10.3 Kcal/mol, justifying the MAO-B high selectivity of these compounds. Both theoretical and experimental structure–activity relationship studies were performed, and substitution patterns were established to increase MAO-B selectivity and inhibitory efficacy. Therefore, we proved that both 3D-QSAR models and molecular docking approaches enhance the probability of finding new potent and selective MAO-B inhibitors, avoiding time-consuming and costly synthesis and biological evaluations.

Synthesis and evaluation of chalcone derivatives as novel sunscreen agent

Jumina, Jumina,Lee, Wonkoo,Swasono, Respati Tri,Wijayanti, Lucia Wiwid

, (2021/05/26)

Ultraviolet (UV) irradiation is a serious problem for skin health thus the interest in the research to develop sunscreen agent has been increasing. Chalcone is a promising compound to be developed as its chromophore absorbs in the UV region. Therefore, in

Continuous-Flow Synthesis of Pyrylium Tetrafluoroborates: Application to Synthesis of Katritzky Salts and Photoinduced Cationic RAFT Polymerization

Sambiagio, Carlo,Ferrari, Matteo,Van Beurden, Koen,Ca', Nicola Della,Van Schijndel, Jack,Noel, Timothy

supporting information, p. 2042 - 2047 (2021/04/05)

Katritzky salts have emerged as effective alkyl radical sources upon metal- or photocatalysis. These are typically prepared from the corresponding triarylpyrylium ions, in turn an important class of photocatalysts for small molecules synthesis and photopolymerization. Here, a flow method for the rapid synthesis of both pyrylium and Katrizky salts in a telescoped fashion is reported. Moreover, several pyrylium salts were tested in the photoinduced RAFT polymerization of vinyl ethers under flow and batch conditions.

Design and synthesis of quinoline-pyrimidine inspired hybrids as potential plasmodial inhibitors

Kayamba, Francis,Malimabe, Teboho,Ademola, Idowu Kehinde,Pooe, Ofentse Jacob,Kushwaha, Narva Deshwar,Mahlalela, Mavela,van Zyl, Robyn L.,Gordon, Michelle,Mudau, Pertunia T.,Zininga, Tawanda,Shonhai, Addmore,Nyamori, Vincent O.,Karpoormath, Rajshekhar

, (2021/03/22)

Presently, artemisinin-based combination therapy (ACT) is the first-line therapy of Plasmodium falciparum malaria. With the emergence of malaria parasites that are resistant to ACT, alternative antimalarial therapies are urgently needed. In line with this

From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity

Abdel-Halim, Mohammad,Sigler, Sara,Racheed, Nora A. S.,Hefnawy, Amr,Fathalla, Reem K.,Hammam, Mennatallah A.,Maher, Ahmed,Maxuitenko, Yulia,Keeton, Adam B.,Hartmann, Rolf W.,Engel, Matthias,Piazza, Gary A.,Abadi, Ashraf H.

supporting information, p. 4462 - 4477 (2021/05/04)

A ligand-based approach involving systematic modifications of a trisubstituted pyrazoline scaffold derived from the COX2 inhibitor, celecoxib, was used to develop novel PDE5 inhibitors. Novel pyrazolines were identified with potent PDE5 inhibitory activit

Synthesis, characterization and structure–activity relationship of non-linear optical response of chalcone derivatives with in silico insights

Rai, Prashant,Chettri, Prajal,Kar, Swayamsiddha,Nagar, Malhar Anupam,Srivastava, Shailesh,Golakoti, Nageswara Rao

supporting information, p. 2603 - 2615 (2021/02/01)

Fifteen chalcone derivatives having D–A–D, D–A–A and A–A–D architectures have been synthesized by Claisen–Schmidt condensation reaction and characterized by UV–Vis, IR, 1H-NMR, 13C-NMR and Mass spectrometry. In order to unambiguously establish the structure–activity relationship for the non-linear optical activity of these compounds, for the first time to our knowledge, we use the femtosecond degenerate four wave mixing (DFWM) technique to quantify and compare the third-order non-linear optical (NLO) activity of all the 15 compounds, under identical conditions. The second harmonics generation (SHG) efficiencies for all the compounds have also been evaluated using the Kurtz-Perry powder method. Among the compounds that we have synthesized here, the ones with A–A–D architecture show the highest NLO activity. Our results show that the NLO activity of a compound with A–A–D architecture can be further enhanced by incorporating a substituent with strong electron withdrawing ability on ring A and strong electron donating substituent on ring B. The results of the in silico studies that we have carried out correlate well with our experimental findings. The compounds (E)-3-(4-(dimethylamino)phenyl)-1-(4-nitrophenyl)prop-2-en-1-one with the compound code (4-N(CH3)2–4′-NO2) and (E)-3-(4-methoxyphenyl)-1-(4-nitrophenyl)prop-2-en-1-one with the compound code (4-MeO-4′-NO2) show the highest NLO activity among the compounds we have reported here. Graphical abstract: [Figure not available: see fulltext.]

Chalcones and bis-chalcones analogs as DPPH and ABTS radical scavengers

Bale, Adebayo Tajudeen,Salar, Uzma,Khan, Khalid Mohammed,Chigurupati, Sridevi,Fasina, Tolulope,Ali, Farman,Ali, Muhammad,Sekhar Nanda, Sitansu,Taha, Muhammad,Perveen, Shahnaz

, p. 249 - 257 (2021/04/21)

Background: A number of synthetic scaffolds, along with natural products, have been identified as potent antioxidants. The present study deals with the evaluation of varyingly substituted, medicinally distinct class of compounds “chalcones and bis-chalcon

New promising levofloxacin derivatives: Design, synthesis, cytotoxic activity screening, Topo2β polymerase inhibition assay, cell cycle apoptosis profile analysis

El-Malah, Afaf,Youssef, Amira,Ismail, Mohamed,Kamel, Mona,Mahmoud, Zeinab

, (2021/06/15)

Newly designed levofloxacin analogues were synthesized to act as topoisomerase II beta inhibitors (Topo2β). Their cytotoxic activity was screened against breast, liver, and leukemia cancer cell lines. The best activity against liver cancer cell line (Hep3B) was exhibited by the target compounds 3c, 3e, 4a, and 6d (IC50 = 2.33, 1.38, 0.60 and 0.43, respectively). (L-SR) leukemia cancer cell line was pronouncedly affected by compounds 3b, 3g and 4a (IC50 = 1.62, 1.41 and 1.61, sequentially). 3c possessed the best activity against breast cancer cell line (MCF-7) with IC50 = 0.66. Compounds 3c, 3e, 3g, 4a and 4c exhibited Topo2β inhibition activities exceeding etoposide and levofloxacin as reference drugs and variant cell lines. In DNA-Flow cytometry cell cycle analysis, compound 3c arrested the cell cycle at G2/M phase like etoposide and levofloxacin, while compounds 3e and 4a exhibit its arrest at S phase. In addition, 3c, 3e and 4a showed a significant elevation in active caspase-3 levels (10.01, 8.98 and 10.71 folds, respectively). The effect of the new compounds on normal cells was also investigated including breast (MCF10a), liver (THLE2), and lymphocytic (PCS-800-011) normal cell lines.

Chalcone-Supported Cardiac Mesoderm Induction in Human Pluripotent Stem Cells for Heart Muscle Engineering

Raad, Farah S.,Khan, Taukeer A.,Esser, Tilman U.,Hudson, James E.,Seth, Bhakti Irene,Fujita, Buntaro,Gandamala, Ravi,Tietze, Lutz F.,Zimmermann, Wolfram

supporting information, p. 3300 - 3305 (2021/09/02)

Human pluripotent stem cells (hPSCs) hold great promise for applications in cell therapy and drug screening in the cardiovascular field. Bone morphogenetic protein 4 (BMP4) is key for early cardiac mesoderm induction in hPSC and subsequent cardiomyocyte derivation. Small-molecular BMP4 mimetics may help to standardize cardiomyocyte derivation from hPSCs. Based on observations that chalcones can stimulate BMP4 signaling pathways, we hypothesized their utility in cardiac mesoderm induction. To test this, we set up a two-tiered screening strategy, (1) for directed differentiation of hPSCs with commercially available chalcones (4’-hydroxychalcone [4’HC] and Isoliquiritigen) and 24 newly synthesized chalcone derivatives, and (2) a functional screen to assess the propensity of the obtained cardiomyocytes to self-organize into contractile engineered human myocardium (EHM). We identified 4’HC, 4-fluoro-4’-methoxychalcone, and 4-fluoro-4’-hydroxychalcone as similarly effective in cardiac mesoderm induction, but only 4’HC as an effective replacement for BMP4 in the derivation of contractile EHM-forming cardiomyocytes.

Fluorine as a robust balancer for tuning the reactivity of topo-photoreactions of chalcones and the photomechanical effects of molecular crystals

Gao, Hongqiang,Lu, Ran,Shu, Yuanhong,Sun, Jingbo,Wang, Haoran,Yang, Xiqiao,Ye, Kaiqi,Yue, Yuan,Zhong, Jiangbin

, p. 5856 - 5868 (2021/09/08)

Fluorine-free chalcones and chalcones bearing different numbers of fluorine atoms have been synthesized. It is found that fluorine can tune the reactivity of photo-induced [2 + 2] cycloaddition reactions in crystals. The higher the number of fluorine atom

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 41564-67-4